Tumor-Infiltrating Lymphocytes in Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer Receiving Neoadjuvant Docetaxel, Carboplatin, Trastuzumab, and Pertuzumab.

Ha, Joo Young; Kim, Jeong Eun; Lee, Hee Jin; Jeong, Jae Ho; Ahn, Jin-Hee; Jung, Kyung Hae; Gong, Gyungyub; Chae, Eun Young; Kim, Hak Hee; Chung, Il Yong; Ko, Beom Seok; Kim, Sung-Bae

Ha, Joo Young; Kim, Jeong Eun; Lee, Hee Jin; Jeong, Jae Ho; Ahn, Jin-Hee; Jung, Kyung Hae; Gong, Gyungyub; Chae, Eun Young; Kim, Hak Hee; Chung, Il Yong; Ko, Beom Seok; Kim, Sung-Bae.

Afiliação

Ha JY; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
Kim JE; Division of Hemato-Oncology, Department of Internal Medicine, Chung-Ang University College of Medicine, Seoul, Korea.
Lee HJ; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
Jeong JH; Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
Ahn JH; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
Jung KH; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
Gong G; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
Chae EY; Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
Kim HH; Department of Radiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
Chung IY; Department of Radiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
Ko BS; Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
Kim SB; Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.